Genenta Science SpA ADR

Genenta Science SpA ADR FCF per Share

The Free Cash Flow per Share of Genenta Science SpA ADR (GNTA) as of Oct 27, 2026 is -0.33 USD. In the previous year, Free Cash Flow per Share was -0.38 USD — a change of -14.06% (higher).

FCF per Share

-0.33USD

YoY

-14.06%

Last updated:

Free Cash Flow per Share of Genenta Science SpA ADR is 2025 -0.33 USD. Free Cash Flow per Share of Genenta Science SpA ADR was 2024 -0.38 USD. It decreases by -14.06% higher compared to the previous year.

The Genenta Science SpA ADR FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
-0.16 USD
Jan 1, 2020
-0.46 USD
Jan 1, 2021
-0.43 USD
Jan 1, 2022
-0.46 USD
Jan 1, 2023
-0.69 USD
Jan 1, 2024
-0.38 USD
Jan 1, 2025
-0.33 USD
The Genenta Science SpA ADR FCF per Share history
YEARFCF per ShareYoY
-0.33USD-14.06%
-0.38USD-44.56%
-0.69USD+50.69%
-0.46USD+6.86%
-0.43USD-7.57%
-0.46USD+198.60%
-0.16USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genenta Science SpA ADR Stock analysis

What does Genenta Science SpA ADR do? Genenta Science S.p.A. generates value by developing hematopoietic stem cell gene therapies for solid tumors in Italy. The company focuses on its product Temferon, which is currently in Phase 1/2a clinical trials for the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. Additionally, the firm is expanding the application of Temferon to other solid tumor indications. The business model relies on a proprietary biologic platform designed to deliver immunomodulatory molecules directly to tumors by infiltrating monocytes and macrophages. As a clinical-stage biotechnology company incorporated in 2014 and headquartered in Milan, Italy, Genenta Science S.p.A. utilizes this platform to advance its therapeutic pipeline and address unmet medical needs in oncology. Genenta Science SpA ADR is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genenta Science SpA ADR stock

Free Cash Flow per Share of Genenta Science SpA ADR is -0.33 USD in 2025.

Free Cash Flow per Share of Genenta Science SpA ADR changed from -0.38 USD to -0.33 USD, representing a -14.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Genenta Science SpA ADR since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Genenta Science SpA ADR

All Key Metrics — Genenta Science SpA ADR